Janux Therapeutics Inc. (JANX)
NASDAQ: JANX
· Real-Time Price · USD
32.10
-1.10 (-3.31%)
At close: May 01, 2025, 3:59 PM
31.52
-1.82%
After-hours: May 01, 2025, 04:48 PM EDT
Janux Therapeutics Revenue
Janux Therapeutics reported an annual revenue of $10.59M, reflecting a 30.99% growth. For the quarter ending December 31, 2024, Janux Therapeutics generated $0 in revenue.
Revenue (ttm)
$10.59M
Revenue Growth
30.99%
Price / Sales Ratio
271.8
Revenue / Employee
$130.72K
Employees
81
Market Cap
1.9B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 10.59M | +30.99% |
| Dec 31, 2023 | 8.08M | -6.14% |
| Dec 31, 2022 | 8.61M | +136.79% |
| Dec 31, 2021 | 3.64M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |